New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Pat
Go back to New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Pat| Amarin Corp Plc (NASDAQ: AMRN) | Delayed: 13.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.48 | 52 Week High | $3.65 | |||
| Open | $13.48 | 52 Week Low | $1.24 | |||
| Day High | $13.48 | P/E | N/A | |||
| Day Low | $13.48 | EPS | $0.00 | |||
| Volume | 50 | |||||
